HCW Biologics
HCWB
HCW Biologics (HCWB) news
Recent news
HCW Biologics reports second quarter 2026 business and clinical development highlights and financial results
AInvest Wire · Aug 14, 2026HCW Biologics, Inc Q2 basic EPS USD -11.58
HCW Biologics, Inc. reported a basic earnings per share (EPS) of -$11.58 for Q2 2026, reflecting continued financial challenges for the company. This result contrasts with the estimated EPS of -$1.98 for the quarter, indicating a significant shortfall relative to expectations . The reported revenue…
AInvest Wire · Aug 14, 2026HCW Biologics - material weakness in technical accounting review control identified - SEC filing
AInvest Wire · Aug 14, 2026HCW Biologics - EPS of $2.19 per share overstated by $0.80 per share for Q1 2026 - SEC filing
AInvest Wire · Aug 14, 2026HCW Biologics - error in two-class method for EPS calculation identified - SEC filing
AInvest Wire · Aug 14, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.